Article ; Online: Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice.
Journal of cutaneous medicine and surgery
2020 Volume 24, Issue 4, Page(s) 418–419
| MeSH term(s) | Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Betacoronavirus ; COVID-19 ; Canada ; Coronavirus Infections/epidemiology ; Humans ; Medication Adherence ; Pandemics ; Pneumonia, Viral/epidemiology ; Psoriasis/drug therapy ; Retrospective Studies ; SARS-CoV-2 ; Thalidomide/analogs & derivatives ; Thalidomide/therapeutic use |
|---|---|
| Chemical Substances | Anti-Inflammatory Agents, Non-Steroidal ; Thalidomide (4Z8R6ORS6L) ; apremilast (UP7QBP99PN) |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-05-12 |
| Publishing country | United States |
| Document type | Letter ; Multicenter Study |
| ZDB-ID | 1361720-5 |
| ISSN | 1615-7109 ; 1203-4754 |
| ISSN (online) | 1615-7109 |
| ISSN | 1203-4754 |
| DOI | 10.1177/1203475420928382 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 4987: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.